الملخص
Objective:To investigate associations between cardiac biomarkers with stroke severity and short-term outcome in patients with acute ischemic stroke (AIS).Methods:Patients with AIS admitted to the Affiliated Hospital of Qingdao University from June 2018 to February 2024 whose etiological classification was large artery atherosclerosis (LAA), small vessel occlusion (SVO) or cardioembolism (CE) were included retrospectively. According to the National Institutes of Health Stroke Scale score at admission, patients were divided into mild stroke group (≤8) and moderate to severe stroke group (>8). According to the modified Rankin Scale score at discharge, patients were divided into good outcome group (≤2) and poor outcome group (>2). Multivariate logistic regression analysis was used to determine the independent correlation between cardiac biomarkers and short-term outcome. The predictive value of cardiac biomarkers for poor outcome in patients with AIS and different stroke etiology subtypes were evaluated using receiver operating characteristic (ROC) curves. Results:A total of 2 151 patients with AIS were enrolled, including 1 256 males (58.4%), aged 67.40±11.34 years. 1 079 patents were LAA type (50.2%), 679 were SVO type (31.6%), and 393 were CE type (18.3%); 1 223 were mild stroke (56.86%) and 928 (43.14%) were moderate to severe stroke; 1 357 patients (63.09%) had good short-term outcome, and 794 (36.91%) had poor short-term outcome. Multivariate logistic regression analysis showed that N-terminal pro-B type natriuretic peptide (NT-proBNP), NT-proBNP/creatine kinase (CK) isoenzyme MB (CK-MB) ratio, and CK-MB/CK ratio were independent risk factors for poor short-term outcome. ROC curve analysis shows that the CK-MB/CK ratio had a higher predictive value for short-term poor outcome in patients with AIS (the area under the curve, 0.859, 95% confidence interval 0.839-0.879). Various cardiac biomarkers had a higher predictive value for short-term outcome of CE type and LAA type, but the predictive value for short-term outcome of SVO type was lower. Conclusions:Cardiac biomarkers are associated with the severity and poor outcome of AIS. NT-proBNP/CK-MB and CK-MB/CK ratios have higher predictive value for short-term poor outcome of AIS, especially in patients with CE type.
الملخص
BACKGROUND:"Tendon off-position"is a disease name included in the International Classification of Diseases 11th Revision,and also a clinical indication of manipulation,acupuncture and other treatments.However,its specific mechanism is still unclear.It is urgent to establish an animal model that can reflect the clinical and pathological characteristics of"tendon off-position,"so as to further study the mechanism of effective clinical treatments. OBJECTIVE:To establish an animal model of"tendon off-position"in rats based on isometric contraction of skeletal muscles,and to explore the changes of skeletal muscle function and morphological phenotype after"tendon off-position." METHODS:Sixty rats were randomly divided into control group,static-loading group and extra loading group,with twenty rats in each group.Rats in the control group were kept normally without treatment.In the latter two groups,the rats were fixed by the self-made static-loading modeling device and a static-loading(the body mass of each rats was applied as the static-loading)was applied to cause sustained isometric contraction of the upper limb muscles.Then,animal models of"tendon off-position"were successfully established.In the extra loading group,50%of the body mass was added to the ankle joint after modeling.The skeletal muscle samples were harvested at 2 and 4 weeks after modeling.The changes of limb grip strength,wet mass of skeletal muscle,and serum levels of creatine kinase-muscle and lactate dehydrogenase A were measured,and the changes of skeletal muscle histomorphology and ultrastructure were observed. RESULTS AND CONCLUSION:At 2 weeks after modeling,the rats in the static-loading group and extra loading group showed significantly decreased grip strength and wet muscle mass,significantly increased serum levels of creatine kinase-muscle and lactate dehydrogenase A,and abnormal muscle fiber morphology and structure accompanied by a large number of deposited collagen fibers.Electron microscopy results showed that the structure of myofibrils was disordered,the Z-line was distorted,and the light and dark boundaries were blurred.At 4 weeks after modeling,the grip strength of the model rats was increased compared with that at 2 weeks,the serum creatine kinase-muscle and lactate dehydrogenase A levels were decreased,and the changes of muscle fiber morphology and ultrastructure were recovered to varying degrees.It is suggested that the rat skeletal muscle injury model based on continuous isometric contraction of skeletal muscle can well reflect the pathological characteristics of"tendon off-position"at 2 weeks,and can be used to study the mechanism of acupuncture and manipulation in the treatment of"tendon off-position."
الملخص
OBJECTIVE:Cold water immersion methods are not standardized in terms of operational indicators such as immersion temperature,duration and depth,leading to controversy over the efficacy of recovery from exercise fatigue in skeletal muscle.In this article,we analyze the effects of cold water immersion on muscle injury,muscle soreness and muscle strength recovery under different factors,in order to find the best immersion implementation plan,and thus provide evidence for the recovery of muscle fatigue. METHODS:A search of CNKI,WanFang Data,Web of Science,and PubMed databases was conducted for relevant literature published from January 1,2000 to August 15,2023.A total of 4 759 articles were initially retrieved,with 4 735 articles excluded through screening and 24 articles finally included.The Physical Therapy Evidence Database Scale was used to assess the methodological quality of the included literature,and Stata-MP 16 software was used to perform effect size combinations,subgroup analyses,Meta-regression,sensitivity tests,and publication bias analyses. RESULTS:(1)The article included a total of 24 randomized controlled trial studies,including 617 subjects,with overall high legal quality.(2)Meta-analysis showed that cold water immersion can significantly reduce creatine kinase blood value[standardized mean difference(SMD)=-0.17,95％confidence interval(CI):-0.29 to-0.05,P<0.01],alleviate muscle pain(SMD=-0.60,95％CI:-0.81 to-0.38,P<0.01),and promote maximum muscle strength recovery(SMD=0.17,95％CI:0.05 to 0.30,P<0.01).(3)Subgroup analysis showed that:The immersing regimen with water temperature>14 ℃(SMD=-0.48,95％CI:-0.76 to-0.20,P<0.01)and duration of 12-14 minutes(SMD=-0.38,95％CI:-0.61 to-0.15,P<0.01)had the best effect in reducing creatine kinase blood values,and had a more significant intervention effect on endurance exercise(SMD=-0.45,95％CI:-0.71 to-0.20,P<0.01),while the immersion regimen with water temperature<10 ℃(SMD=-0.61,95％CI:-0.79 to-0.43,P<0.01),duration<12 minutes(SMD=-0.76,95％CI:-0.98 to-0.53,P<0.01),and immersion depth above the iliac spine(SMD=-0.74,95％CI:-0.97 to-0.52,P<0.01)had the best effect on relieving muscle soreness,and had a more significant analgesic effect after endurance exercise(SMD=-0.42,95％CI:-0.61 to-0.22,P<0.01).(4)Meta regression showed that immersion water temperature,immersion duration,and exercise type were important regulatory factors affecting the effect size of creatine kinase;immersing water temperature and immersing depth were important regulatory factors affecting the effect size of visual analogue scale score,while exercise type was an important regulatory factor affecting the maximum isometric muscle strength effect size. CONCLUSION:(1)Evidence of extremely low to moderate strength suggests that cold water immersion can effectively reduce muscle damage,alleviate muscle soreness,and promote muscle strength recovery.(2)In terms of reducing muscle injury,immersion water temperature,immersion duration,and exercise type are significant regulatory factors that affect the efficacy of immersing.Among them,immersion water temperature>14 ℃ and duration of 12-14 minutes are the best solutions to reduce muscle injury after exercise,and the immersing effect is better for endurance exercise.(3)In terms of reducing muscle soreness,immersion water temperature and immersion depth are important regulatory factors that affect the intervention effect.Among them,immersion water temperature<10 ℃,duration<12 minutes,and immersing depth above the iliac spine are the best solutions to reduce muscle soreness,and have a better analgesic effect after endurance exercise.(4)In terms of promoting muscle strength recovery,exercise type is a key regulatory factor that affects the maximum isometric muscle strength effect.
الملخص
Objective:To analyze the clinical value of dynamic electrocardiogram combined with serum brain natriuretic peptide (BNP) and creatine kinase isoenzyme (CK-MB) levels in evaluating the severity of respiratory tract infection complicated with viral myocarditis.Methods:A total of 125 patients with respiratory tract infection who were admitted to the Affiliated Run Run Shaw Hospital of Medical School, Zhejiang University from January 2018 to December 2022 were selected retrospectively. They were divided into the complication group (71 cases) and the non-complication group (54 cases) according to whether they were complicated with viral myocarditis. Dynamic and conventional electrocardiogram characteristics were compared. Serum BNP and CK-MB levels in the complication group and the non-complication group at admission were analyzed. Dynamic electrocardiograms and serum BNP and CK-MB levels of patients with different severity of myocarditis were comparatively analyzed. The value of combined diagnosis was analyzed.Results:The detection rates of atrial premature beats and sinus tachycardia by dynamic electrocardiogram were higher than those by conventional electrocardiogram: 38.03% (27/71) vs. 22.54% (16/71), 28.17% (20/71) vs. 14.08% (10/71) ( P<0.05). Serum BNP and CK-MB levels in the complication group were higher than those in the non-complication group: (104.26 ± 10.75) ng/L vs. (54.11 ± 5.69) ng/L, (17.89 ± 1.86) U/L vs. (13.46 ± 1.42) U/L ( P<0.05). The detection rates of atrial premature beats, sinus tachycardia, burst ventricular tachycardia, first-degree atrioventricular block, ST segment change and low QRS voltage, serum BNP and CK-MB levels in patients with respiratory tract infection complicated with severe viral myocarditis (37 cases) were higher than those in patients with mild viral myocarditis (34 cases): 51.35% (19/37) vs. 23.53% (8/34), 43.24% (16/37) vs. 11.76% (4/34), 32.43% (12/37) vs. 11.76% (4/34), 29.73% (11/37) vs. 8.82% (3/34), 43.24% (16/37) vs. 14.71% (5/34), 24.32% (9/37) vs. 5.88% (2/34), (107.19 ± 10.56) ng/L vs. (101.08 ± 10.18) ng/L, (18.33 ± 1.85) U/L vs. (17.41 ± 1.76) U/L ( P<0.05). Compared with clinical pathological diagnosis, Kappa values of dynamic electrocardiogram, BNP at admission, CK-MB at admission and combination of the three for diagnosing acute upper respiratory tract infection complicated with viral myocarditis were 0.784, 0.765, 0.733 and 0.879. The sensitivity and accuracy of combined diagnosis were higher. Conclusions:Dynamic electrocardiogram combined with serum BNP and CK-MB can better help to evaluate the severity of respiratory tract infection complicated with myocarditis. Therefore, they are worthy of monitoring.
الملخص
Objective:To correlate serum Nesfatin-1, N-terminal pro-brain natriuretic peptide (NT-proBNP), and cystatin C (CysC) levels with myocardial enzymes and cardiac function in patients with acute ST-elevation myocardial infarction (STEMI).Methods:This is a case-control study. A total of 100 patients with acute STEMI who received treatment at Lishui People's Hospital from January 2020 to December 2022 were included in the STEMI group. An additional 80 healthy controls who concurrently received physical examinations in the same hospital were included in the control group. Serum levels of Nesfatin-1, NT-proBNP, CysC, creatine kinase-MB (CK-MB), and cardiac troponin I (cTnI) levels were determined in each group. Left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVDD), and left ventricular end-systolic diameter (LVDS) were measured using color Doppler ultrasound. Correlation analysis was performed.Results:Serum Nesfatin-1 level in the STEMI group was (89.96 ± 15.25) ng/L, which was significantly lower than (226.36 ± 37.47) ng/L in the control group ( t = 33.15, P < 0.05). Serum levels of NT-proBNP and CysC in the STEMI group were (1 325.12 ± 378.48) ng/L and (1.37 ± 0.24) mg/L, which were significantly higher than (78.95 ± 13.42) ng/L and (0.79 ± 0.16) mg/L in the control group ( t = -29.42, -18.56, both P < 0.05). Serum CK-MB and cTnI levels in the STEMI group were (46.51 ± 12.14) U/L and (1.13 ± 0.25) U/L, respectively, which were significantly higher than (12.23 ± 4.01) U/L and (0.09 ± 0.02) U/L in the control group ( t = -24.06, -37.09, both P < 0.05). The LVEF in the STEMI group was (37.84 ± 5.45)%, which was significantly lower than (72.41 ± 4.26)% in the control group ( t = 46.49, P < 0.05). The LVDD and LVDS in the STEMI group were (40.92 ± 5.25) mm and (58.98 ± 6.25) mm, which were significantly higher than (19.86 ± 3.36) mm and (34.21 ± 4.38) mm in the control group ( t = -31.13, -30.03, both P < 0.05). Serum Nesfatin-1 level was positively correlated with LVEF ( r = 0.572), but it was negatively correlated with serum CK-MB and cTnI levels, LVDD, and LVDS ( r = -0.498, -0.617, -0.506, -0.534, all P < 0.05). Serum NT-proBNP and CysC levels were negatively correlated with LVEF ( r = -0.653, -0.607), but they were positively correlated with serum CK-MB and cTnI levels, LVDD, and LVDS ( r = 0.582, 0.526, 0.712, 0.565, 0.631, 0.578, 0.659, 0.635, all P < 0.05). Conclusion:Serum Nesfatin-1 levels decrease, while serum NT-proBNP and CysC levels increase in patients with acute STEMI. Serum Nesfatin-1, NT-proBNP, and CysC levels are closely related to myocardial enzymes and cardiac function.
الملخص
Objective:To explore the evaluation value of serum levels of positive pentameric protein 3 (PTX3) and creatine kinase isoenzyme MB (CK-MB) on volume load in patients with chronic decompensated heart failure (CDHF).Methods:A total of 300 CDHF patients who visited the Xingtai Central Hospital from July 2019 to July 2022 were selected and divided into a capacity overload group ( n=182) and a non capacity overload group ( n=118) based on their capacity balance level. Two clinical data sets were compared and analyzed. The receiver operating characteristic (ROC) curve was used to analyze the evaluation value of serum PTX3 and CK-MB levels on the volume load of CDHF patients. The clinical disease characteristics of the two groups of patients were analyzed using univariate analysis, and the influencing factors of volume load of CDHF patients were analyzed using logistic regression. A column chart model was constructed and validated. Results:The body mass index (BMI), waist circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose (FBG), glycosylated hemoglobin (HbA 1c), C-reactive protein (CRP), uric acid (UA), homeostasis model assessment of insulin resistance (HOMA-IR) of patients in the capacity overload group were higher than those in the non-capacity overload group, and the differences were statistically significant (all P<0.05). The PTX3, CK-MB, pulmonary capillary wedge pressure (PCWP), and CVP levels of patients in the capacity overload group were higher than those in the non-capacity overload group, while albumin, hemoglobin, and hematocrit were lower than those in the non-capacity overload group, and the differences were statistically significant (all P<0.05). The ROC curve showed that the area under the curve (AUC) of PTX3 and CK-MB for predicting capacity overload in CDHF patients are 0.795 and 0.718, with sensitivity of 86.2% and 83.7%, specificity of 65.4% and 68.6%, respectively, indicating high predictive accuracy; The AUC of the two joint predictions is 0.817, the sensitivity was 92.5%, and the specificity was 70.6%. The prediction accuracy was higher than PTX3 ( Z=3.812, P<0.05) and CK-MB ( Z=3.365, P<0.05). PTX3, CK-MB, albumin, hemoglobin, hematocrit, PCWP, and central venous pressure (CVP) were all influencing factors of volume load status in CDHF patients (all P<0.05). The column chart risk prediction model established based on these factors had high accuracy and strong applicability in clinical treatment. Conclusions:Serum PTX3 and CK-MB levels are influencing factors for volume overload in CDHF patients. A column chart model constructed in combination with indicators such as albumin, hemoglobin, hematocrit, PCWP, and CVP has high predictive value for the volume overload status of CDHF.
الملخص
ABSTRACT Introduction: The evidence for using del Nido cardioplegia protocol in high-risk patients with reduced ejection fraction undergoing isolated coronary surgery is insufficient. Methods: The institutional database was searched for isolated coronary bypass procedures. Patients with ejection fraction < 40% were selected. Propensity matching (age, sex, infarction, number of grafts) was used to pair del Nido (Group 1) and cold blood (Group 2) cardioplegia patients. Investigation of biomarker release, changes in ejection fraction, mortality, stroke, perioperative myocardial infarction, composite endpoint (major adverse cardiac and cerebrovascular events), and other perioperative parameters was performed. Results: Matching allowed the selection of 45 patient pairs. No differences were noted at baseline. After cross-clamp release, spontaneous sinus rhythm return was observed more frequently in Group 1 (80% vs. 48.9%; P=0.003). Troponin values were similar in both groups 12 and 36 hours after surgery, as well as creatine kinase at 12 hours. A trend favored Group 1 in creatine kinase release at 36 hours (median 4.9; interquartile range 3.8-9.6 ng/mL vs. 7.3; 4.5-17.5 ng/mL; P=0.085). Perioperative mortality, rates of myocardial infarction, stroke, or major adverse cardiac and cerebrovascular events were similar. No difference in postoperative ejection fraction was noted (median 35.0%; interquartile range 32.0-38.0% vs. 35.0%; 32.0-40.0%; P=0.381). There was a trend for lower atrial fibrillation rate in Group 1 (6.7% vs. 17.8%; P=0.051). Conclusion: The findings indicate that del Nido cardioplegia provides satisfactory protection in patients with reduced ejection fraction undergoing coronary bypass surgery. Further prospective trials are required.
الملخص
La miositis aguda benigna asociada a influenza es una complicación esporádica. En Argentina, en el año 2022, hubo un aumento temprano de la circulación de influenza y del número total de las notificaciones, con la aparición de miositis secundarias. Serie clínica retrospectiva de nueve pacientes pediátricos que consultaron por dolor e impotencia funcional de extremidades inferiores, y enzimas musculares elevadas, en el hospital Pedro de Elizalde de la Ciudad Autónoma de Buenos Aires, entre agosto y octubre del 2022. En todos se detectó infección por virus influenza y se recuperaron sin secuelas. La miositis aguda benigna es una entidad infrecuente en la infancia, cuyo diagnóstico es predominantemente clínico y de recuperación ad integrum. Debe ser sospechada en pacientes con clínica compatible en contexto de alta circulación viral. La vigilancia epidemiológica aporta herramientas para identificar los virus circulantes y sus posibles complicaciones.
Benign acute myositis associated with influenza is a sporadic complication. In Argentina, in 2022, there was an early increase in influenza circulation and the total number of notifications, with the appearance of secondary myositis. Retrospective clinical series of nine pediatric patients who consulted for pain and functional impotence of the lower extremities, and elevated muscle enzymes, at the Pedro de Elizalde hospital in the Autonomous City of Buenos Aires, between August and October 2022. In all of them, infection by influenza virus and recovered without sequelae. Benign acute myositis is a rare entity in childhood, whose diagnosis is predominantly clinical and recovery ad integrum. It should be suspected in patients with compatible symptoms in a context of high viral circulation. Epidemiological surveillance provides tools to identify circulating viruses and their possible complications.
الموضوعات
Humans , Male , Female , Child, Preschool , Child , Influenza, Human/complications , Myositis/complications , Argentina , Creatine Kinase/analysis , Influenza, Human/diagnosis , Influenza, Human/epidemiology , Real-Time Polymerase Chain Reaction , Hospitals, Pediatric , Myositis/diagnosis , Myositis/epidemiologyالملخص
Objective: This study aimed to find the common inborn errors of metabolism in Iranian patients with autism spectrum disorder. Methods: In this cross-sectional multicenter study, 105 children and adolescents with autism spectrum disorder from six centers in different cities of Iran were enrolled between August, 2019 and October, 2020. Metabolic screening, including measuring plasma levels of amino acids, acylcarnitines, creatine, and guanidinoacetate, and urinary levels of organic acids, purines, and pyrimidines was performed. Other data, including age, parental consanguinity, history of seizure, developmental mile-stones, and physical examination, were also recorded. Results: An inborn error of metabolism was found in 13 (12.4%) patients. Five patients (4.8%) had cerebral creatine deficiency syndrome, 4 (3.8%) had arginine succinate aciduria, 2- methylbutyryl glycinuria, short-chain acyl-CoA dehydrogenase deficiency, and combined methylmalonic aciduria/malonic aciduria. There was a strong association between positive metabolic evaluation and parental consanguinity, history of seizures, microcephaly, and delayed development. Conclusions: Our results suggest that metabolic screening should be performed in the cases of autism associated with parental consanguinity, developmental delay, and a history of seizures. The assays to be considered as a screening panel include plasma or blood amino acids, acylcarnitines, creatine and guanidinoacetate, and urinary levels of organic acids.
الملخص
Objective:To investigate the clinical efficacy of alteplase combined with heparin in the treatment of acute moderate- and high-risk pulmonary thromboembolism and its effects on arterial blood gas analysis and myocardial enzyme level.Methods:Seventy-eight patients with acute moderate- and high-risk pulmonary thromboembolism who received treatment in Dongyang People's Hospital from January 2015 to January 2022 were retrospectively included in this study. They were divided into observation ( n = 39) and control ( n = 39) groups according to different treatment methods. The control group was treated with heparin, while the observation group was treated with alteplase based on heparin. All patients were treated for 7 days. Clinical efficacy as well as arterial blood gas analysis, myocardial enzymes, pulmonary artery pressure, and tricuspid annular plane systolic excursion pre- and post-treatment were compared between the two groups. Results:The total response rate in the observation group was significantly higher than that in the control group (94.87% vs. 76.92%, χ2 = 5.18, P < 0.05). After treatment, the partial pressure of carbon dioxide in the observation group was significantly lower than that in the control group [(36.24 ± 5.12) mmHg vs. (44.25 ± 3.78) mmHg, 1 mmHg = 0.133 kPa, t = 7.86, P < 0.05]. After treatment, the partial pressure of oxygen in the observation group was significantly higher than that in the control group [(78.82 ± 5.1) mmHg vs. (71.23 ± 4.89) mmHg, t = 6.66, P < 0.05]. After treatment, lactate dehydrogenase, creatine kinase, and creatine kinase isoenzyme in the observation group were (107.42 ± 15.45) U/L, (37.21 ± 10.84) U/L, and (12.28 ± 3.54) U/L, respectively, which were significantly lower than (189.94 ± 21.20) U/L, (65.42 ± 6.57) U/L, and (19.29 ± 3.08) U/L in the control group ( t = 19.64, 13.89, 9.33, all P < 0.001). After treatment, the pulmonary arterial pressure in the observation group was significantly lower than that in the control group [(32.24 ± 3.86) mmHg vs. (37.79 ± 5.17) mmHg, t = 5.37, P < 0.001]. Tricuspid annular plane systolic excursion in the observation group was significantly higher than that in the control group [(14.07 ± 1.27) mm vs. (12.63 ± 1.16) mm, t = 5.22, P < 0.001]. Conclusion:Ateplase combined with heparin has an obvious effect on acute moderate- and high-risk pulmonary thromboembolism. It can improve arterial blood gas analysis and reduce myocardial enzyme levels.
الملخص
Objective:To investigate the value of multi-slice spiral CT (MSCT) combined with three myocardial markers in the diagnosis of acute chest pain etiology.Methods:A retrospective study was conducted on 120 patients with acute chest pain admitted to the Affiliated Hospital of Jining Medical University from January 2020 to December 2020. All patients underwent MSCT imaging examination upon admission, and serum creatine kinase isoenzyme MB (CK-MB), troponin I (cTnI), and myoglobin (MYO) levels were also tested. The final clinical diagnosis was used as the judgment standard to draw a 2×2 four-square table, and calculate the value of MSCT, CK-MB, cTnI, and MYO in the diagnosis of acute chest pain etiology.Resultsl:Among the 120 acute chest pain patients included, 75 were diagnosed with acute coronary syndrome (62.50%), 16 with aortic dissection (13.33%), and 29 with pulmonary embolism (24.17%). The coincidence rate of MSCT diagnosis of coronary heart disease was 86.67%(65/75), the diagnosis of aortic dissection coincidence rate was 12/16, and the diagnosis of pulmonary embolism coincidence rate was 75.86%(22/29). The serum CK-MB, cTnI, and MYO levels in the coronary heart disease group were significantly higher than those in the aortic dissection group and pulmonary embolism group, and the differences were statistically significant (all P<0.05). There was no significant difference in serum CK-MB, cTnI, and MYO levels between the aortic dissection group and pulmonary embolism group (all P>0.05). The sensitivity of CK-MB, cTnI, and MYO in the differential diagnosis of acute chest pain patients with coronary heart disease and non-coronary heart disease were 93.33%, 85.33%, and 89.33%, respectively, and the specificity were 73.33%, 80.00%, and 77.78%, respectively. The areas under the receiver operating characteristic (ROC) curve were 0.833, 0.826, and 0.836, respectively. Conclusions:MSCT can better identify coronary heart disease, aortic dissection, and pulmonary embolism in patients with acute chest pain, while the three myocardial markers can better distinguish patients with coronary heart disease and non-coronary heart disease. Therefore, MSCT combined with myocardial markers should be used for the diagnosis of acute chest pain patients in clinical practice to facilitate early clinical diagnosis.
الملخص
{L-End}Objective To analyze the local muscle response under continuous ergonomic workload by simulating manual lifting, and to screen the sensitive metabolic biomarkers during fatigue process. {L-End}Methods A total of 13 healthy male volunteers were selected as the study subjects using simple random sampling method. Study subjects underwent repetitive simulated manual lifting for four periods (T1 to T4), each lasting 12 minutes. The degree of work-related fatigue in the forearm, upper arm, shoulder, back, and leg muscles, and the whole body was accessed using Borg 6-20 Rating of Perceived Exertion (RPE) Scale. The venous blood samples were collected from elbow between each two periods to detect the levels of eight metabolic biomarkers: ammonia, lactate, creatine kinase, lactate dehydrogenase (LDH), C-terminal telopeptide of type Ⅰ collagen (CTX-Ⅰ), C-terminal telopeptide of type Ⅱ collagen (CTX-Ⅱ), cartilage oligomeric matrix protein (COMP), and calcium ions. {L-End}Results The RPE scores of the study subjects for the muscles of five body parts and the whole body increased with the increasing lifting periods (all P<0.01). Fatigue was observed in all target muscles, with overall body fatigue occurring in the T2 period. The levels of ammonia, lactate, creatine kinase, LDH, COMP, and calcium ions in the serum of study subjects were higher in the T1 to T4 periods than in the T0 period (all P<0.05). The serum CTX-Ⅰ level was higher in the T1 and T3 periods than that in the T0 period (all P<0.05) , and the serum CTX-Ⅱ level was higher in the T1, T2 and T4 periods than that in the T0 period (all P<0.05). The level of these eight serum metabolic biomarkers fluctuated during the T1 to T4 periods. The serum creatine kinase level increased with the period of lifting (all P<0.05). The serum lactate level was higher in the T3 period than those in the T1 and T2 periods (all P<0.05). The serum LDH and calcium ion levels were higher in the T2 to T4 periods than that in the T1 period (all P<0.05). The serum COMP level was higher in the T2 and T3 periods than that in the T1 period (all P<0.05). Except for CTX-Ⅰ, the levels of other seven metabolic markers in serum were higher in individuals after fatigue than before fatigue (all P<0.05). {L-End}Conclusion Serum metabolic biomarkers such as ammonia, lactate, creatine kinase, calcium ions, LDH, CTX-Ⅱ, and COMP exhibit significant changes before and after fatigue. These metabolic biomarkers could be used as sensitive biomarkers for evaluating muscle fatigue during repetitive works.
الملخص
Introducción: El entrenamiento deportivo es un proceso que requiere una planificación orientada a la adaptación del cuerpo a las cargas internas versus cargas externas; de allí, surge la necesidad de conocer el comportamiento de algunas enzimas musculoesqueléticas a través del control bioquímico y fisiológico del entrenamiento en el atletismo de medio fondo. Objetivo: Analizar los cambios enzimáticos de la creatinfosfoquinasa y la lactodeshidrogenasa durante el entrenamiento anaeróbico láctico y su influencia en la capacidad aeróbica en atletas de medio fondo. Método: Se utilizó el método descriptivo comparativo con una muestra de 20 sujetos aleatorizados en dos grupos: experimental y control; el análisis se realizó bajo el modelo estadístico Anova descriptiva, pruebas T y diseño de medidas repetidas con un intervalo del 95 por ciento de confianza (p<0,05). Resultados: En las variables creatinfosfoquinasa y lactodeshidrogenasa inicial y final no hubo variaciones significativas intergrupos; se observaron diferencias en la creatinfosfoquinasa en varianza (p=0,022) del orden del 97,8 por ciento; que en promedio (p=0,088) representó los niveles alcanzados del 91,2 por ciento. En las medidas repetidas no se presentaron cambios estadísticamente significativos intergrupos. Para la variable del VO2máx se aplicó la prueba T para comparar los estados inicial y final en cada grupo y hubo diferencias en ambos grupos (control p=0,002; experimental p=0,000). Conclusiones: No hubo cambios enzimáticos importantes durante los entrenamientos anaeróbico láctico y aeróbico, a su vez, el entrenamiento anaeróbico láctico si tuvo influencia en la capacidad aeróbica(AU)
Introduction: Sports training is a process that requires a planning oriented to the adaptation of the body to internal loads versus external loads; from there, arises the need to know the behavior of some musculoskeletal enzymes through the biochemical and physiological control of training in middle-distance athletics. Objective: To analyze the enzymatic changes of creatine phosphokinase and lactodehydrogenase during lactic anaerobic training and their influence on aerobic capacity in middle-distance athletes. Methods: The descriptive comparative method was used with a sample of 20 subjects randomized in two groups: experimental and control; the analysis was performed under the descriptive Anova statistical model, T-tests and repeated measures design with a 95 percent confidence interval (p<0.05). Results: In the initial and final creatine phosphokinase and lactodehydrogenase variables, there were no significant intergroup variations; differences were observed in creatine phosphokinase regarding variance or standard deviation (p=0.022) in the order of 97.8 percent; which in average (p=0.088) represented the levels reached of 91.2 percent. In the repeated measures, there were no statistically significant intergroup changes. For the VO2max variable, the T-test was applied to compare the initial and final states in each group and there were differences in both groups (control p=0.002; experimental p=0.000). Conclusions: There were no important enzymatic changes during lactic anaerobic and aerobic training, and lactic anaerobic training had an influence on aerobic capacity(AU)
الموضوعات
Humans , Exercise , Endurance Training/methods , Oxygen Consumption , Track and Field/education , Comparative Study , Epidemiology, Descriptiveالملخص
ABSTRACT Introduction: Quercetin (Q) is a flavonoid that has been shown to be an antioxidant in vitro. A current review is necessary to evaluate whether Q can improve biochemical damage markers following exercise-induced muscle damage (EIMD) and delayed onset muscle soreness (DOMS). Objective: Specify the impact of Q supplementation on EIMD, DOMS, and inflammatory cytokines (IL-6, IL-10, and TNF-α) after exercise. Methods: Participants (n=28) were randomly assigned to Q (1000 mg/day) and placebo (PLA). Intake was done 48 hours before EMID to 96 hours after EMID (one week). Before EIMD (PRE) and 24, 48, 72, and 96 hours after EIMD, blood samples were collected for CK and measurement of inflammatory cytokines. ANOVA test was used for data analysis with a significance P > 0.05. Results: Peak DOMS was seen 48 hours after EIMD, regardless of the DOMS combination. Q had a significant reducing effect on CK response at 24 hours (-43%), 48 hours (-48%), 72 hours (-56%), and 96 hours (-67%) after EIMD compared to placebo. IL-10 and IL-6 did not change statistically for the applied sample size. TNF-α was lower by Q intake significantly at 24 hours (-24%), 48 hours (-22%), and 96 hours (-22%) compared to PLA. Furthermore, the TNF-α trend was lower with Q intake at 72 hours (-19%). Conclusion: Q supplementation decreased biological inflammation during post-IMD recovery but not quadriceps DOMS. Level of Evidence: Therapeutic Studies - Investigating Treatment Outcomes.
RESUMO Introdução: A quercetina (Q) é um flavonóide que provou ser um antioxidante in vitro. Fez-se necessária uma revisão atual projetada para avaliar se a Q pode melhorar os marcadores bioquímicos de dano após o dano muscular induzido pelo exercício (EIMD) e a dor muscular de início retardado (DOMS). Objetivo: O objetivo da revisão atual foi especificar o impacto da suplementação Q sobre EIMD, DOMS e citocinas inflamatórias (IL-6, IL-10 e TNF-α) após o exercício. Métodos: Os participantes (n=28) foram alocados em Q (1000 mg/dia) e placebo (PLA) aleatoriamente. Fez-se ingestão 48 horas antes da EMID a 96 horas após a EMID (uma semana). Antes da EIMD (PRE) e 24, 48, 72 e 96 horas após a EIMD, amostras de sangue coletadas para CK e medição de citocinas inflamatórias. O teste ANOVA foi usado para análise de dados com significância P > 0,05. Resultados: O pico DOMS foi visto em 48 horas após EIMD, independentemente da combinação de DOMS. Q teve um efeito de redução significativo na resposta CK em 24 horas (-43%), 48 horas (-48%), 72 horas (-56%) e 96 horas (-67%) após a EIMD em comparação com placebo. IL-10 e IL-6 não mudaram estatisticamente para o tamanho da amostra aplicada. TNF-α foi menor pela ingestão de Q significativamente às 24 horas (-24%), 48 horas (-22%), e 96 horas (-22%) em comparação com o PLA. Ademais, a tendência TNF-α foi menor com a ingestão de Q às 72 horas (-19%). Conclusão: A suplementação de Q diminuiu a inflamação biológica durante a recuperação pós EIMD, porém não os DOMS do quadríceps. Nível de evidência: Estudos Terapêuticos - Investigando os Resultados de tratamento.
RESUMEN Introducción: La quercetina (Q) es un flavonoide que ha demostrado ser un antioxidante in vitro. Por ello, es necesaria una revisión actual diseñada para evaluar si la Q puede mejorar los marcadores bioquímicos de daño tras el daño muscular inducido por el ejercicio (EIMD) y el dolor muscular de aparición retardada (DOMS). Objetivo: El objetivo de la presente revisión fue especificar el impacto de la suplementación con Q en el EIMD, el DOMS y las citoquinas inflamatorias (IL-6, IL-10 y TNF-α) después del ejercicio. Métodos: Los participantes (n=28) fueron asignados aleatoriamente a Q (1000 mg/día) y a placebo (PLA). La ingesta se realizó desde 48 horas antes de la EMID hasta 96 horas después de la misma (una semana). Antes de la EMID (PRE) y 24, 48, 72 y 96 horas después de la EMID, se tomaron muestras de sangre para la CK y la medición de citoquinas inflamatorias. Se utilizó la prueba ANOVA para el análisis de los datos con una significancia P > 0,05. Resultados: El pico de DOMS se observó en las 48 horas posteriores a la EIMD, independientemente de la combinación de DOMS. Q tuvo un efecto significativamente reductor en la respuesta de la CK a las 24 horas (-43%), 48 horas (-48%), 72 horas (-56%) y 96 horas (-67%) después de la EIMD en comparación con el placebo. La IL-10 y la IL-6 no cambiaron estadísticamente para el tamaño de muestra aplicado. El TNF-α se redujo significativamente con la ingesta de Q a las 24 horas (-24%), a las 48 horas (-22%) y a las 96 horas (-22%) en comparación con el PLA. Además, la tendencia del TNF-α fue menor con la ingesta de Q a las 72 horas (-19%). Conclusión: La suplementación con Q disminuyó la inflamación biológica durante la recuperación después de un IMD, pero no el DOMS del cuádriceps. Nivel de evidencia: Estudios terapéuticos -Investigación de los resultados del tratamiento.
الملخص
ABSTRACT Introduction: Cherry extract has a high amount of anthocyanins and flavonoids containing antioxidant effects. Its high antioxidant characteristics have been shown to reduce markers of delayed muscle soreness (DOMS) and exercise-induced muscle damage (EIMD) to improve recovery after exercise. Objective: Verify the effects of the cherry extract on post-exercise muscle damage. Methods: Google scholar, Medline, and Scopus were systematically searched until February 2022. The Cochrane Collaboration tool was applied to determine the risks of bias. Results: The results showed that cherry extract administration did not have a decreasing impact on creatine kinase levels overall: (WMD = 12.85 IU. L-1, 95% CI: −35.94, 61.64; P = 0.606). Considerable heterogeneity was observed among the articles (Cochran's Q-test = 990.80, P = 0.000, I2 = 96.7 %). However, there is a significant reducing effect on pain sensation by the consumption of cherry extract (WMD = −6.105 mm; 95% CI: −11.193 −1.017; p = 0.019). Conclusion: Cherry extract consumption effectively reduced late-onset muscle pain among participants in the overall and subgroup analysis. Thus, the cherry extract may be a complementary alternative in recovery after exercise. Level of evidence II; Therapeutic studies - Manuscript review.
RESUMO Introdução: O extrato de cereja tem uma alta quantidade de antocianinas e flavonóides contendo efeitos antioxidantes. Suas altas características antioxidantes demonstraram reduzir os marcadores de dor muscular retardada (DOMS) e dano muscular induzido pelo exercício (EIMD) para melhorar a recuperação após o exercício. Objetivo: Verificar os efeitos do extrato de cereja nos danos musculares pós-exercício. Métodos: Google scholar, Medline e Scopus foram sistematicamente pesquisados até fevereiro de 2022. A ferramenta de colaboração da Cochrane foi aplicada para determinar os riscos de viés. Resultados: Os resultados mostraram que a administração do extrato de cereja não teve um impacto decrescente nos níveis de creatina quinase em geral: (WMD = 12,85 IU. L-1, 95% CI: −35,94, 61,64; P = 0,606). Uma heterogeneidade considerável foi observada entre os artigos (teste Q da Cochran = 990,80, P = 0,000, I2 = 96,7 %). Porém, há um efeito redutor significativo na sensação de dor pelo consumo de extrato de cereja (WMD = −6,105 mm; 95% CI: −11,193 −1,017; p = 0,019). Conclusão: O consumo de extrato de cereja foi efetivo na redução de dores musculares de início tardio entre os participantes, na análise geral e nos subgrupos. Assim, o extrato de cereja pode ser uma alternativa complementar na recuperação após os exercícios. Nível de evidência II; Estudos terapêuticos - Revisão de manuscritos.
RESUMEN Introducción: El extracto de cereza tiene una gran cantidad de antocianinas y flavonoides con efectos antioxidantes. Se ha demostrado que sus altas características antioxidantes reducen los marcadores de dolor muscular retardado (DOMS) y el daño muscular inducido por el ejercicio (EIMD) para mejorar la recuperación después del ejercicio. Objetivo: Verificar los efectos del extracto de cereza en el daño muscular posterior al ejercicio. Métodos: Se realizaron búsquedas sistemáticas en Google scholar, Medline y Scopus hasta febrero de 2022. Se aplicó la herramienta de colaboración Cochrane para determinar los riesgos de sesgo. Resultados: Los resultados mostraron que la administración de extracto de cereza no tuvo un impacto decreciente en los niveles de creatina quinasa en general: (WMD = 12,85 UI. L-1, IC del 95%: −35,94, 61,64; P = 0,606). Se observó una considerable heterogeneidad entre los artículos (prueba Q de Cochran = 990,80, P = 0,000, I2 = 96,7 %). Sin embargo, el consumo de extracto de cereza tiene un efecto significativo de reducción del dolor (WMD = −6,105 mm; IC del 95%: −11,193 −1,017; p = 0,019). Conclusión: El consumo de extracto de cereza fue eficaz para reducir el dolor muscular de aparición tardía entre los participantes en el análisis global y de subgrupos. Así, el extracto de cereza puede ser una alternativa complementaria en la recuperación después de los ejercicios. Nivel de evidencia II; Estudios terapéuticos - Revisión de manuscritos.
الملخص
ABSTRACT Introduction: Exercise-induced muscle damage (EIMD) can occur from recent or unusual physical activity, leading to a temporary reduction in muscle function. And increased pain. Several articles indicate the positive impacts of creatine on EIMD. Objective: Evaluate the impact of creatine on EIMD. Methods: Online searches were performed in Scopus, Embase, Medline and Google scholar until March 2022. Results: Thirteen studies met the inclusion criteria. To assess the quality of the studies, the Cochrane collaboration system was used for risk and bias analysis. Due to the high heterogeneity of interventions and studies designed, a meta-analysis was not performed. The current paper reveals that creatine intake is preferable to inactive recovery and only a rest period between several harmful and exhausting physical activities. Conclusion: Benefits were attenuated in EIMD markers that reduce muscle operation and muscle strength loss after exercise. Level of evidence II; Therapeutic studies - Manuscript review.
RESUMO Introdução: O dano muscular induzido pelo exercício (EIMD) pode acontecer por atividade física recente ou não habitual e leva a uma redução temporária da função muscular. e aumento da dor. Vários artigos indicam impactos positivos da creatina sobre a EIMD. Objetivo: Avaliar o impacto da creatina sobre a EIMD. Métodos: Foram feitas pesquisas eletrônicas em Scopus, Embase, Medline e Google scholar até março de 2022. Resultados: Treze estudos preencheram os critérios de inclusão. Para avaliar a qualidade dos estudos, o sistema de colaboração Cochrane foi utilizado na análise de risco e viés. Devido à alta heterogeneidade de intervenções e estudos desenhados, a meta-análise não foi realizada. As informações do documento atual revelam que a ingestão de creatina é preferível a uma recuperação inativa e apenas um período de repouso entre diversas atividades físicas prejudiciais e exaustivas. Conclusão: Os benefícios evidenciaram-se atenuados nos marcadores EIMD que reduzem a operação muscular e a perda de força muscular após os exercícios. Nível de evidência II; Estudos terapêuticos - Revisão de manuscritos.
RESUMEN Introducción: el daño muscular inducido por el ejercicio (EIMD) puede producirse por una actividad física reciente o inusual y provoca una reducción temporal de la función muscular y un aumento del dolor. Varios artículos indican impactos positivos de la creatina en la EIMD. Objetivo: Evaluar el impacto de la creatina en la EIMD. Métodos: Se realizaron búsquedas electrónicas en Scopus, Embase, Medline y Google scholar hasta marzo de 2022. Resultados: Trece estudios cumplieron los criterios de inclusión. Para evaluar la calidad de los estudios, se utilizó el sistema de colaboración Cochrane para el análisis de riesgos y sesgos. Debido a la gran heterogeneidad de las intervenciones y de los estudios diseñados, no se realizó un metanálisis. La información del presente documento revela que la ingesta de creatina es preferible a una recuperación inactiva y sólo un período de descanso entre varias actividades físicas perjudiciales y agotadoras. Conclusión: Los beneficios se mostraron atenuados en los marcadores EIMD que reducen el funcionamiento muscular y la pérdida de fuerza muscular después del ejercicio. Nivel de evidencia II; Estudios terapéuticos - Revisión de manuscritos.
الملخص
ABSTRACT Introduction: Evidence indicates that whey protein supplementation may accelerate tissue repair and be useful for exercise-induced muscle injury (EIMD) by accelerating recovery and elevating protein synthesis and blood amino acids. However, the potential role of whey protein after EIMD in humans is inconsistent. Objective: Find the effective role of whey protein in post-exercise recovery from EIMD. Methods: Scopus, Medline, and Google scholar, were systematically searched until March 2022. To assess the risk of bias, the Cochrane collaboration tool was applied. Weighted mean differences (WMD), 95% confidence intervals (CI), and random effect models to calculate the total effect. Results: The result of the review indicated that the decreasing impact of whey protein intake is significant on creatine kinase (CK) [WMD = −19.11 IU.L-1, CI: −36.200, −2.036; P = 0.028]. The effect of whey protein supplementation on lactate dehydrogenase (LDH) concentration indicated that the impact of whey protein on changing LDH levels is significant. In addition, subgroup analysis showed significant decreases in CK and LDH based on post-exercise follow-up times, whey protein dosage, test duration, supplementation time, exercise types, and training status. Conclusion: The results showed the efficacy of whey protein in decreasing CK and LDH levels among adults in general and in subgroup analysis. Therefore, whey protein could have an effective role in the post-exercise recovery of EIMD. Level of evidence II; Therapeutic studies - review of results.
RESUMO Introdução: As evidências indicam que a suplementação de proteína de soro de leite pode acelerar a reparação tecidual e, portanto, ser útil para as lesões musculares induzidas pelo exercício (EIMD), acelerando a recuperação, além de elevar a síntese proteica e os aminoácidos sanguíneos. Entretanto, o papel potencial da proteína de soro de leite após a EIMD em humanos, é inconsistente. Objetivos: Encontrar a função efetiva da proteína de soro de leite na recuperação pós exercício de EIMD. Métodos: Scopus, Medline e Google scholar foram sistematicamente pesquisados até março de 2022. Para avaliar o risco de viés, foi aplicada a ferramenta de colaboração Cochrane. Diferenças médias ponderadas (WMD), intervalos de confiança de 95% (CI) e modelos de efeito aleatório foram utilizados para o cálculo do efeito total. Resultados: O resultado da revisão indicou que o impacto decrescente do consumo de proteína de soro de leite é significativo na creatina quinase (CK) [WMD = −19,11 IU.L-1, CI: −36,200, −2,036; P = 0,028]. O efeito da suplementação proteica do soro de leite na concentração de desidrogenase láctica (LDH) indicou que o impacto da proteína do soro de leite na mudança dos níveis de LDH é significativo. Além disso, a análise dos subgrupos mostrou diminuição significativa na CK e LDH, com base nos tempos de acompanhamento após o exercício, dosagem da proteína do soro de leite, duração dos testes, tempo de suplementação, tipos de exercício e status de treinamento. Conclusão: Os resultados mostraram a eficácia da proteína de soro de leite na diminuição dos níveis de CK e LDH entre adultos, em geral e na análise dos subgrupos. Portanto, a proteína do soro de leite poderia ter uma função eficaz na recuperação pós exercício de EIMD. Nível de evidência II; Estudos terapêuticos - revisão dos resultados.
RESUMEN Introducción: Las pruebas indican que la suplementación con proteína de suero de leche puede acelerar la reparación de los tejidos y, por lo tanto, ser útil para las lesiones musculares inducidas por el ejercicio (EIMD) al acelerar la recuperación, así como elevar la síntesis de proteínas y los aminoácidos en sangre. Sin embargo, el papel potencial de la proteína de suero después de la EIMD en los seres humanos, es inconsistente. Objetivos: Encontrar el papel efectivo de la proteína de suero de leche en la recuperación posterior al ejercicio de EIMD. Métodos: Se realizaron búsquedas sistemáticas en Scopus, Medline y Google scholar hasta marzo de 2022. Para evaluar el riesgo de sesgo, se aplicó la herramienta de colaboración Cochrane. Para calcular el efecto total se utilizaron diferencias medias ponderadas (WMD), intervalos de confianza (CI) del 95% y modelos de efectos aleatorios. Resultados: El resultado de la revisión indicó que el impacto decreciente de la ingesta de proteína de suero es significativo en la creatina quinasa (CK) [WMD = −19,11 UI.L-1, IC: −36,200, −2,036; P = 0,028]. El efecto de la suplementación con proteína de suero en la concentración de lactato deshidrogenasa (LDH) indicó que el impacto de la proteína de suero en el cambio de los niveles de LDH es significativo. Además, el análisis de subgrupos mostró disminuciones significativas de la CK y la LDH en función de los tiempos de seguimiento tras el ejercicio, la dosis de proteína de suero, la duración de la prueba, el tiempo de suplementación, los tipos de ejercicio y el estado de entrenamiento. Conclusión: Los resultados mostraron la eficacia de la proteína de suero en la disminución de los niveles de CK y LDH entre los adultos en general y en el análisis de subgrupos. Por lo tanto, la proteína de suero podría tener un papel eficaz en la recuperación posterior al ejercicio de EIMD. Nivel de evidencia II; Estudios terapéuticos - revisión de resultados.
الملخص
ABSTRACT Introduction Biochemical indicators such as blood urea nitrogen and creatine kinase in young athletes are ways to test their fitness. These data provide the basis for assessing young athletes' physical and functional fitness during training. Objective Investigate serum urea nitrogen levels and creatine kinase levels in weightlifters. Methods 12 biomarkers of athletes were tracked and observed in this article. After this study, it was found that changes were observed in their physiological parameters. These changes are usually found every three weeks. The method of mathematical statistics was used to analyze the data obtained. Results The average creatine kinase levels were significantly elevated in the first cycle. These data differ from the basal level (P<0.01). The increased serum urea nitrogen and creatine kinase levels indicate that the athlete has entered a state of fatigue. Conclusion Blood urea nitrogen and creatine kinase levels are essential in determining the degree of fatigue and sports injuries in athletes. Level of evidence II; Therapeutic studies - investigation of treatment outcomes.
RESUMO Introdução Indicadores bioquímicos como nitrogênio ureico no sangue e creatina quinase em atletas jovens são formas de testar a aptidão física. Esses dados fornecem a base para avaliar o condicionamento físico e funcional que os jovens atletas precisam durante o treinamento. Objetivo Investigar os níveis de nitrogênio sérico ureico e creatina quinase em halterofilistas. Métodos 12 biomarcadores de atletas foram rastreados e observados neste artigo. Após este estudo, constatou-se que foram observadas mudanças em seus parâmetros fisiológicos. Estas mudanças são geralmente encontradas a cada três semanas. Utilizou-se o método de estatística matemática para analisar os dados obtidos. Resultados Os níveis médios de creatina quinase foram significativamente elevados no primeiro ciclo. Estes dados são bastante diferentes do nível basal (P<0,01). O aumento do nível sérico de nitrogênio ureico e creatina quinase indica que o atleta entrou em um estado de fadiga. Conclusão Os níveis de nitrogênio ureico no sangue e creatina quinase têm um papel essencial na determinação do grau de fadiga e lesões esportivas dos atletas. Nível de evidência II; Estudos terapêuticos - investigação dos resultados do tratamento.
RESUMEN Introducción Los indicadores bioquímicos como el nitrógeno ureico en sangre y la creatina quinasa en jóvenes atletas son formas de comprobar su estado físico. Estos datos proporcionan la base para evaluar la aptitud física y funcional que necesitan los jóvenes atletas durante el entrenamiento. Objetivo Investigar los niveles de nitrógeno ureico sérico y creatina quinasa en levantadores de pesas. Métodos En este artículo se examinaron y observaron 12 biomarcadores de atletas. Tras este estudio, se observaron cambios en sus parámetros fisiológicos. Estos cambios suelen producirse cada tres semanas. Para analizar los datos obtenidos se utilizó el método de la estadística matemática. Resultados Los niveles medios de creatina-cinasa fueron significativamente elevados en el primer ciclo. Estos datos son muy diferentes del nivel basal (P<0,01). El aumento de los niveles de nitrógeno ureico sérico y de creatina-cinasa indica que el atleta ha entrado en un estado de fatiga. Conclusión Los niveles de nitrógeno ureico en sangre y de creatina quinasa tienen un papel esencial en la determinación del grado de fatiga y de las lesiones deportivas en los atletas. Nivel de evidencia II; Estudios terapéuticos - investigación de los resultados del tratamiento.
الملخص
HyperCKemia is a rare condition characterized by a persistent increase in serum creatine kinase (CK) levels or some isoenzymes. Usually, there are no clinical, electromyography or histological manifestations, which involves a challenge at the time of diagnosis. The patient in question showed no characteristic signs or symptoms, apart from fatigue and post-exercise myalgia. Assessment was performed by rheumatology and endocrinology, determination of total CK and MB fraction in blood, and electromyography and protein electrophoresis were requested as part of the approach. This case report is considered as novel, interesting, and useful for clinical practice as few similar ones were found in the scientific literature. The difficult etiological diagnosis of this entity, and the algorithm used to arrive at it, are all presented. It is concluded that in those patients with hyperCKemia of unknown etiology, this diagnosis should be kept in mind, and be confirmed by performing a CK electrophoresis.
La hiperCKemia es una condición poco frecuente caracterizada por un aumento persistente de los niveles de creatina quinasa (CK) sérica o de algunas isoenzimas, sin que suelan presentarse manifestaciones clínicas, electromiográficas o histológicas, lo cual implica un desafío a la hora del diagnóstico. El paciente cuyo caso se presenta aquí no mostró signos o síntomas característicos, únicamente fatiga y mialgias posteriores al ejercicio. Se llevó a cabo valoración por reumatología y endocrinología, determinación de CK total y fracción MB en sangre; además, se solicitó electromiografía y electroforesis de proteínas como parte del abordaje. Consideramos que este reporte de caso es novedoso, interesante y de utilidad para la práctica clínica pues se encuentran pocos similares en la literatura científica; adicionalmente, se pone en evidencia el difícil diagnóstico etiológico de esta entidad, así como el algoritmo utilizado para llegar a ella. Se concluye que este diagnóstico debe tenerse en mente en aquellos pacientes con hiperCKemia de etiología desconocida, y para confirmarlo es necesario hacer una electroforesis de CK.
الموضوعات
Humans , Male , Adult , Transferases , Creatine Kinase , Enzymes and Coenzymes , Enzymesالملخص
Introducción: caracterizar los deportistas es fundamental. En fútbol profesional se efectúa, aunque no de forma estandarizada. Esta investigación es la primera fase de un modelo de evaluación y seguimiento. Objetivo: describir el perfil de las variables del control biomédico y deportivo en un equipo de futbolistas profesionales. Métodos: estudio descriptivo en 32 futbolistas. Variables agrupadas en: 1) identificación; 2) antecedentes deportivos; 3) antropométricas; 4) monitoreo del entrenamiento; 5) fuerza; 6) GPS. Las mediciones se efectuaron según protocolo estandarizado. Se presentan las medias y desviaciones estándar (DE), medianas y rango intercuartíl (RIQ), y frecuencias relativas. En componentes claves se efectúan análisis por posición de juego. Resultados: la edad media fue 24,0 ± 4,6. El tiempo como profesional fue de 5,5 años. Las lesiones ligamentarias y musculares fueron los antecedentes más comunes con 31,5 % y 22,9 %, respectivamente; el 71,0 % ocurrieron en competencia. Los arqueros y delanteros tuvieron mayores porcentajes de masa adiposa. Defensas y volantes presentaron las mayores distancias recorridas con 64.560 y 64.386 metros, respectivamente. Los defensas y delanteros alcanzaron las mayores frecuencias de sprint (>27km/h). Los mayores desequilibrios de fuerza lo registraron los arqueros (50 % rodilla izquierda), seguidos de un 33,0 % en los volantes. Se evidenció alta heterogeneidad en los valores de creatina quinasa (CPK). Conclusión: un modelo estandarizado e interdisciplinario permite determinar el estado nutricional y antecedentes, monitorizar la carga y perfil de juego, evaluar los desequilibrios y marcadores de sobrecarga muscular; con miras a reducir el riesgo de lesiones y aumentar el rendimiento.
Summary Introduction: Characterizing athletes is essential. In professional soccer it is done, although not in a standardized way. This research is the first phase of an evaluation and monitoring model. Objective: To describe the profile of the variables of biomedical and sports control in a team of professional soccer players. Methods: Descriptive study in 32 soccer players. Variables were grouped in: 1) identification; 2) sports background; 3) anthropometry; 4) training monitoring; 5) strength; 6) GPS. Measurements were made according to standardized protocol. The means and standard deviations (SD), medians and interquartile range (IQR) and relative frequencies are presented. Analysis by playing position is carried out on key components. Results: The mean age was 24.0 ± 4.6. The time as a professional was 5.5 years. Ligament and muscle injuries were the most common antecedents with 31.5% and 22.9%, respectively; 71.0% occurred in competition. Goalkeepers and forwards had higher percentages of fat mass. Defenders and midfielders had the longest distances covered with 64.560 and 64.386 meters, respectively. Defenders and forwards reached the highest sprint frequencies (>27km /h). The greatest strength imbalances were recorded by goalkeepers (50% left knee), followed by 33.0% in midfielders. High heterogeneity was evidenced in creatine kinase (CPK) values. Conclusion: A standardized and interdisciplinary model allows determining nutritional status and antecedents, monitoring load and playing profile, evaluating imbalances and muscle overload markers; with the aim of reducing the risk of injury and increasing performance.